Hylenex recombinant and Swelling - a phase IV clinical study of FDA data

Summary:

Swelling is reported as a side effect among people who take Hylenex recombinant (hyaluronidase recombinant human), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Botox Cosmetic, and have Post procedural complication.

The phase IV clinical study analyzes which people have Swelling when taking Hylenex recombinant. It is created by eHealthMe based on reports of 151 people who have side effects when taking Hylenex recombinant from the FDA, and is updated regularly.

What is Hylenex recombinant?

Hylenex recombinant has active ingredients of hyaluronidase recombinant human. eHealthMe is studying from 152 Hylenex recombinant users. Check the latest studies of Hylenex recombinant.

What is Swelling?

Swelling is found to be associated with 2,299 drugs and 2,891 conditions by eHealthMe. Check the latest studies of Swelling.

On Jul, 12, 2026

151 people reported to have side effects when taking Hylenex recombinant.
Among them, 13 people (8.61%) have Swelling.

Could Hylenex recombinant cause Swelling?

Among these 13 people:

How long have people been on Hylenex recombinant when they have Swelling? *

What is the gender of people who have Swelling when taking Hylenex recombinant? *

female: 100 %
male: 0.0 %

What is the age of people who have Swelling when taking Hylenex recombinant? *

What are other drugs people take besides Hylenex recombinant? *

What are other side effects people have besides Swelling? *

Burning Sensation: 4 people, 30.77%
Joint Pain: 2 people, 15.38%
Skin Atrophy (wasting of skin): 2 people, 15.38%
Itching: 2 people, 15.38%
Pain: 2 people, 15.38%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 2 people, 15.38%
Hypersensitivity: 2 people, 15.38%
Rashes (redness): 2 people, 15.38%
Injection Site Erythema (redness at injection site): 1 person, 7.69%
Weight Decreased: 1 person, 7.69%

What are the existing conditions these people have? *

Post Procedural Complication: 6 people, 46.15%
Skin Wrinkling (wrinkle on skin): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Hylenex recombinant and have Swelling?

- Check whether Swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hylenex recombinant:

Hylenex recombinant (152 reports)

Swelling treatments and more:

Swelling (115,742 reports)

How severe was Swelling and when was it recovered:

Swelling in Hylenex recombinant

Expand to all the drugs that have ingredients of hyaluronidase recombinant human:

Swelling and drugs with ingredients of hyaluronidase recombinant human (54 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hylenex recombinant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling:

Swelling (2,299 drugs)

Browse all the conditions that are associated with Swelling:

Swelling (2,891 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hyaluronidase recombinant human (the active ingredients of Hylenex recombinant) and Hylenex recombinant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.